Analysts expect that Senseonics Holdings, Inc. (NASDAQ:SENS) will report earnings of ($0.14) per share for the current quarter, Zacks reports. Two analysts have made estimates for Senseonics’ earnings, with the highest EPS estimate coming in at ($0.06) and the lowest estimate coming in at ($0.19). Senseonics reported earnings per share of ($0.16) in the same quarter last year, which would indicate a positive year over year growth rate of 12.5%. The company is expected to report its next earnings report on Thursday, May 9th.

According to Zacks, analysts expect that Senseonics will report full year earnings of ($0.56) per share for the current fiscal year, with EPS estimates ranging from ($0.75) to ($0.25). For the next fiscal year, analysts forecast that the company will report earnings of ($0.46) per share, with EPS estimates ranging from ($0.62) to ($0.24). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that cover Senseonics.

Senseonics (NASDAQ:SENS) last announced its earnings results on Tuesday, March 12th. The company reported ($0.04) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.15) by $0.11. The firm had revenue of $7.20 million for the quarter, compared to the consensus estimate of $7.89 million.

NASDAQ:SENS remained flat at $$2.08 during midday trading on Monday. The company had a trading volume of 908,731 shares, compared to its average volume of 1,795,580. Senseonics has a 1 year low of $2.00 and a 1 year high of $5.29.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.

See Also: How to trade on quiet period expirations

Get a free copy of the Zacks research report on Senseonics (SENS)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.